A

Akari Therapeutics (AKTX)

$000.00 0.00% ($0.00)

Today
Week
Month
Year
5 Year
YTD

baraka

getbaraka.com

About Akari Therapeutics (AKTX)

Akari Therapeutics, Plc is a late-stage biotechnology company developing advanced therapies for autoimmune and inflammatory diseases. The Company's lead asset, investigational nomacopan, is a bispecific recombinant inhibitor of complement C5 activati... Read more

Open
USD1.12
High
USD1.14
Low
USD1.12
52 Week High
USD4.40
Monthly Return
-9.90%
Revenue
--

Daily Vol.
6.02k
Avg. Daily Vol.
22.95k
Market Cap.
38M
52 Week Low
0.85
Annual Return
-61.30%

Stock News

Best Stock to Buy Right Now: Uber vs. Tesla

Best Stock to Buy Right Now: Uber vs. Tesla

Yahoo

Social Security touts customer-service milestones, but some say it’s ‘cherry picking’ performance improvements

Social Security touts customer-service milestones, but some say it’s ‘cherry picking’ performance improvements

MarketWatch

TSA plans to let travelers keep their shoes on at airport security checkpoints

TSA plans to let travelers keep their shoes on at airport security checkpoints

CNBC

Here are winners and losers of Tuesday's stealth market rotation — plus, Nvidia $4T watch

Here are winners and losers of Tuesday's stealth market rotation — plus, Nvidia $4T watch

CNBC

Unlock More Stock Analysis & Reports

Access detailed stock analysis from LSEG including analyst price target estimates.

Build Your Long Term Wealth

Build Your Long Term Wealth

A modern investment app with fair pricing.

Top Movers

This list tracks the stocks with the most upwards (top gainers) and downwards (top losers) movement in price from the previous day.

Not sure which stock to invest in?

Not sure which stock to invest in?

Get access to easy in-depth stock analysis and reports from Refinitiv with analyst estimates on share price movements.